Seeking Alpha

IBB
iShares Nasdaq Biotechnology ETF

5/26/2012, 11:14 AM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
IBB Market Currents more »
  • May 14 Biotech ETFs are near all-time highs despite overall market weakness, due to successful trials - e.g. for Vertex's (VRTX) cystic fibrosis treatment - and because some investors are betting on deals occurring. One ETF that is doing particularly well this year is iShares Nasdaq Biotech (IBB). Others include XBI, FBT and BBH.
    2 Comments
    [Healthcare]
ETF Stats
  • Expense Ratio: 0.48%
  • Average Bid Ask Ratio: 0.06%
  • Tracking Error: 0.12%
  • Concentration Risk: 16.98%
  • Capital Gains Dist. %: 0.00%
  • Number of Securities: 118
  • Dividend Amount: $0.014456
  • Dividend Date: 12/22/2011
For overall rating and ranking versus other ETFs get a free trial to XTF Premium
IBB in Focus more »
IBB Press Releases and Filings more »
Currently, there are no press releases or filings on IBB.
IBB Cramer more »
Currently, there are no Cramer articles on IBB.
IBB Instablog posts more »
  • 2 Defensive ETFs To Consider For A Sideways Market
    Mon, May 14 • John R. Conway • Comment!
  • APPLE STILL DRIVES MARKETS
    Mon, Mar 19 • David Fry • Comment!
  • BULL REAWAKENS ON THURSDAY
    Thu, Feb 23 • David Fry • Comment!
  • HIGH GAS PRICES SLOW RALLY
    Tue, Feb 21 • David Fry • Comment!
  • TOP 5 BIOTECH ETFs
    Wed, Feb 15 • David Fry • Comment!
Write a post on IBB
IBB StockTalks
IBB vs. ETF Alternatives
IBB Description
The iShares Nasdaq Biotechnology Index Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of companies primarily engaged in the biotechnology industry, as represented by the NASDAQ Biotechnology Index<sup>®</sup>.
See more details on sponsor's website
Sector: Healthcare
Country: United States
Key Info